Clinical Trial: Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: An Open-label, Long-term, Prospective, Observational Study to Monitor the Safety and Effectiveness of Ilaris in CAPS Patients

Brief Summary: The purpose of this observational study is to collect additional information regarding long-term safety and effectiveness of Ilaris in the treatment of CAPS patients in clinical practice.